S Kase, W Saito, K Ohgami, K Yoshida, N … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: The histopathological findings demonstrated that PDR membranes
consisted of a variety of endothelial cells forming a microvascular cavity with
red blood cells and non-vascular stromal mononuclear cells. Membranous and ... Cited by 15 - Related articles - BL Direct - All 3 versions
JB Jonas, M Neumaier - Clin Exp Ophthalmol, 2007 - interscience.wiley.com The purpose of this study was to evaluate whether the concentration of
erythropoietin as another potent ischemia-induced angiogenic factor is elevated
in eyes with neovascular (age-related macular degeneration [AMD]) or ... Cited by 7 - Related articles - All 4 versions
CJ Diskin, TJ Stokes, LM Dansby, L Radcliff, … - The American Journal of the Medical Sciences, 2007 - journals.lww.com Skip Navigation Links Home > October 2007 - Volume 334 - Issue 4 > A Hypothesis:
Can Erythropoietin Administration Affect the S... ... A Hypothesis: Can
Erythropoietin Administration Affect the Severity of Retinopathy in ... Cited by 9 - Related articles - BL Direct - All 3 versions
S Kuriyama, H Tomonari, G Tokudome, Y … - Hypertension research: official journal of the Japanese …, 2001 - ncbi.nlm.nih.gov The association of the angiotensinogen (AGT) gene variation at codon 235, the
T235 variant, with hypertension induced by erythropoietin (Epo) was investigated
in patients with progressive renal disease requiring treatment for renal ... Cited by 10 - Related articles - BL Direct - All 3 versions
T Zhou, C Xu, M He, Y Sun - Prostate Cancer and Prostatic Diseases, 2007 - nature.com The aim of the present study was to investigate the differential expression of
erythropoietin receptor (EPOR) in prostate carcinoma (PCa), high-grade prostatic
intraepithelial neoplasia (PIN), prostatic hyperplasia (BPH) lesions and ... Cited by 2 - Related articles - BL Direct - All 3 versions
MÈ Rodrigue, S Lacasse-M, R Larivière, M … - Canadian journal of physiology and pharmacology, 2005 - ingentaconnect.com Page 1. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for
prostacyclin in erythropoietin- induced hypertension in uremic rats ... Cited by 2 - Related articles - BL Direct - All 7 versions
S Nagarajan, E Mansfield, S Hsieh, R Liu, F … - Clinical Transplantation, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 3 - Related articles - BL Direct - All 5 versions
- ►nih.gov Z Tong, Z Yang, S Patel, H Chen, D Gibbs, X … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences Significant morbidity and mortality among patients with diabetes mellitus result
largely from a greatly increased incidence of microvascular complications.
Proliferative diabetic retinopathy (PDR) and end stage renal disease (ESRD) ... Cited by 12 - Related articles - BL Direct - All 7 versions
J Chen, KM Connor, CM Aderman, LEH Smith - The Journal of Clinical Investigation, 2008 - pubmedcentral.nih.gov Erythropoietin (Epo), a hormone known to stimulate bone marrow erythrocyte
production, is widely used to treat anemia in patients at risk for vascular
disease. However, the effects of Epo on angiogenesis are not well defined. ... Cited by 35 - Related articles - BL Direct - All 10 versions
M Lebel, ME Rodrigue, M Agharazii, R … - American Journal of Hypertension, 2006 - Elsevier Correcting anemia with recombinant human erythropoietin (rhEPO) in chronic renal
failure has been associated with an increased blood pressure (BP), which may
accelerate the decline in renal function. This has been attributed, in ... Cited by 6 - Related articles - All 4 versions
